Learn more about us

How we are transforming patient care

Learn more about us

How we are transforming patient care

ILÚM Health Solutions is now part of Infectious Disease Connect

ILÚM Health Solutions would like to announce that, effective March 31, 2020, the company has become part of Infectious Disease Connect (ID Connect). Together, the new combined entity serves hospitals in 8 states.

ID Connect’s clinical ID, pharmacy, and nursing experts, along with ILUM’s infectious disease decision support platform, will enhance the delivery of care across the patient continuum. By combining precision medicine and data science with the expertise of world-class, academic ID clinicians, the new combined entity can reduce the time to optimal therapy by delivering the definitive patient-specific treatment right when it is needed, benefiting both the patient and the hospital. Learn more at idctelemed.com

Our Mission

is to help hospitals and healthcare institutions provide the highest quality of care possible.

Our Vision

is to guide the clinician to the best choice for the first dose of antibiotics and to the definitive answer before the second dose is due.

Who We Serve

Our goal is to help providers across all health system venues make tangible improvements to the health of their patients.

In addition to health systems, ILÚM is working with organizations such as the CDC, State Departments of Health, and countries seeking to impede the exponential problems driven by infectious diseases, to make a broader impact on public health around the world.

Who We Serve

Our goal is to help providers across all health system venues in the continuum of care, and to make tangible improvements to the health of their patients.

In addition to health systems, ILÚM is working with organizations such as the CDC and state Departments of Health, as well as countries seeking to impede the exponential problems driven by infectious diseases, to make a broader impact on public health around the world.

Our Leadership

Paul Edwards

President & Chief Executive Officer
A message from our CEO

Antibiotics are one of the world’s most precious resource. More and more data suggests that by the year 2050 very few of today’s antibiotics will be active and antibiotic resistance will likely account for more deaths across the world than all forms of cancer combined. What we do at ILÚM is and will be critically important in slowing down the current rate of antibiotic resistance. Ensuring the appropriate use of antibiotics, needs to be our stated mission, as protecting these precious resources will save many lives for generations to come.

About Paul Edwards

Paul joined ILÚM Health Solutions in 2014 as President and Chief Executive Officer. Paul’s current responsibilities include leading all facets of the business into one core strategy. He is also responsible for partnerships with companies that align with ILÚM’s core technologies including precision medicine, clinical decision support and outcomes-based eco-systems.

Paul has been with Merck for 21 years and has held several leadership positions during his tenure, including; Global Brand Leader – Infectious Diseases; Business Operations Director; Franchise Leader and European Marketing Director (EMEAC).

In these roles, Paul has gained leadership experience both in the US and abroad and has held both strategic and operational positions. Paul has focused on infectious disease, antimicrobial stewardship and precision medicine from a global perspective long before the topic was a focus. He has been a member of or lead teams that have implemented Antimicrobial Stewardship Programs in many countries around the world, most notably Russia, India, South Africa and Colombia. It is from this global perspective that Paul understands the critical importance of focusing on patient and hospital outcomes.

Paul holds an MBA from Oxford Brookes University in the United Kingdom.

EVP & Chief Operating Officer

Riaan Erwee, CA(SA)

AS ILÚM’s Chief Operating Officer, Riaan is responsible for leading the overall operations and finances of the organization, as well as business development activities.

Riaan is one of the co-founders of ILÚM and has over 25 years of experience operating across a broad spectrum of functions in Finance, Operations, Supply Chain Management and Global ERP Systems Deployment in the US and abroad.

Riaan spent over 21 years with Merck & Co., Inc. most recently as Executive Director in Business Development, Strategy & Operations, which included sourcing and closing multiple deals and managing the execution of strategic corporate initiatives from incubation to full scale operations. Riaan also served as a board member on invested entities. In previous roles, Riaan has contributed his business acumen and analytic skills to create value for the company by simplifying manufacturing, regulatory and supply chain operations, as well as transforming business processes managed with ERP systems. Riaan started his career as an external auditor at E&Y.

Riaan is a Chartered Accountant (CA) and holds a Honors Bachelor of Accounting Science from the University of South Africa and a Bachelor of Commerce in Accountancy from the University of Pretoria. He was also a Certified Supply Chain Professional (CSCP) from the American Production and Inventory Control Society (APICS).

SVP & Chief Innovation Officer

W. Joseph Ketcherside, MD FAANS

Joe Ketcherside, MD is an experienced medical informaticist and business leader with a strong clinical and industry background. As Chief Innovation Officer, Joe is part of senior management and is responsible for identifying and developing new strategies for ILÚM as we focus on Precision Medicine for Infectious Diseases, and he leads the Clinical Team. He is the project lead and executive champion for ILÚM’s state-wide system to track multi-drug resistant organisms for the New York State Department of Health.

Dr. Ketcherside was the co-founder of Cognovant, Inc., a consumer health informatics company specializing in mobile, personal health technologies and the creator of  the PocketHealth mobile PHR platform. He was Chief Medical Officer of Quire, LLC, a data analytics company with artificial intelligence systems that uncover population-wide trends and patterns in unstructured Electronic Medical Record text. As CEO of Ketcherside Group, LLC, an independent consultant to health systems and technology companies, he provided strategic insight for technology adoption and product development.

Dr. Ketcherside graduated from the Pritzker School of Medicine at the University of Chicago, and practiced neurosurgery for 11 years in Kansas City, MO in a community practice as well as serving as Chief of Neurosurgery at the University of Missouri – Kansas City. After further education in the Software Architecture Department at UMKC, he left clinical practice to work with Cerner Corp as an engineer, physician executive, and product management director for physician systems. He subsequently worked at TheraDoc, Inc. as Chief Medical Officer and VP for Corporate Strategies.

Dr. Ketcherside then served as Senior VP and CMIO for Methodist Healthcare in Memphis TN, where he led their EMR and CPOE initiatives. He was also the co-director of the Biomedical Informatics Unit of the University of Tennessee Health Sciences Center Clinical and Translational Science Institute, which he helped to create. Following that, he was CMIO at Heartland Health in St. Joseph MO, and the Medical Director for the Lewis and Clark Information Exchange, a regional HIE. In all of these roles, he was responsible for system design, implementation and adoption across the enterprise.

SVP & Chief Technology Officer

Jonathan Olson

Jonathan Olson has spent more than 20 years developing and implementing clinical informatics solutions. This journey to improve the quality of healthcare has taken him from hospital IT departments to multiple start-ups, two of which resulted in being acquired.

He served as CTO at TheraDoc, ActiveCare and VisualShare addressing problems in diabetes management and imaging informatics. Now with ILÚM Health Solutions he is focusing on infectious diseases. Jonathan is a computer scientist with additional training in bioinformatics.

Our Journey

  • 2014

    Merck launch to address AMR

  • 2015

    Development partner

  • 2017

    Mobile solution for emerging markets


  • 2017


    Acquired joint development partner

  • 2018


    Product officially launched

  • 2018


    Distribution agreement executed – exclusive channel for hospitals with >150 beds

  • 2018


    New York Stat DOH Surveillnce

Our Partners

ILÚM continuously evaluates strategic and tactical partnerships with leading healthcare organizations. We seek to align with innovative companies that share the same passion ILÚM has for enhancing the delivery of care across the patient continuum. Our interest is seeking those that complement our portfolio of solutions and services to help deliver transformative programs. Together, we drive great performance.

ILÚM Health Solutions is a subsidiary of Merck Healthcare Services and Solutions.